“What works for whom and why? Revealing neural mechanisms of change in psychotherapy for treatment-resistant persistent depressive disorder” Acronym: MapPDD (Mechanisms of chAnge in Psychotherapy for Persistent Depressive Disorder) Today we received a rejection of our DFG-Antrag MapPDD involving a network six German universities: Daniel Keeser, Munich; Ivo Heitland, Hanover; Katja Bertsch, Munich; Eva-Lotta Brakemeier, Greifswald; Jan Richter, …
Long-COVID depression (LoCODe) Today we received a rejection of our BMBF-application “LoCODe”. Topic: i) To understand and characterise long-COVID depression (LoCODe) clinically and via biomarkers that discern depressive patients with and without prior SARS-CoV-2 infection. ii) To enable stratified therapeutic observations and targeted interventional trials. iii) To discern adaptational or incidental depression from a post infectious …
SOCIAL SUPPORT, SLEEP, OPTIMISM & ANTI-VIRAL IMMUNE DEFENSE – S3O AVID Today we received a complete rejection of our DFG-Antragspaket S3O AVID involving a network of 18 physicians and scientists from Kiel, Lübeck, Hamburg, Stockholm and Nijmegen with interdisciplinary expertise in immunology, rheumatology, psychiatry, psychology, anaesthesiology, intensive care medicine, oncology and virology. Our submission was part of the “Call for …
